Showing results (1161-1170 of 1,171) with videos related to
Sort By:
Pageof 118
Journal of Cardiology|February 3, 2023
Shorter door-to-balloon time, better long-term clinical outcomes in ST-segment elevation myocardial infarction patients: J-MINUET substudyRyota Nishio, Manabu Ogita, Satoru Suwa, et al.International Heart Journal|March 17, 2020
Admission During Off-Hours Does Not Affect Long-Term Clinical Outcomes of Japanese Patients with Acute Myocardial InfarctionSatoru Suwa, Manabu Ogita, Hideki Ebina, et al.Heart and Vessels|November 18, 2017
A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudyTakuya Hashimoto, Junya Ako, Koichi Nakao, et al.BMC Cancer|February 2, 2017
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I studyShingo Miyamoto, Fusanori Yotsumoto, Taeko Ueda, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|April 2, 2019
Admission Heart Rate Is a Determinant of Effectiveness of Beta-Blockers in Acute Myocardial Infarction PatientsTaishi Okuno, Jiro Aoki, Kengo Tanabe, et al.Heart and Vessels|April 21, 2021
Validation of the atherothrombotic risk score for secondary prevention in patients with acute myocardial infarction: the J-MINUET studyTakuya Hashimoto, Yoshiyasu Minami, Junya Ako, et al.Journal of Clinical Medicine|June 6, 2020
Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary VasospasmRyota Sato, Kenji Sakamoto, Koichi Kaikita, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|June 3, 2021
Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy - Insights From the J-MINUET StudyYousuke Hashimoto, Yukio Ozaki, Shino Kan, et al.Stem Cell Research & Therapy|March 6, 2025
First-in-human clinical study of an embryonic stem cell product for urea cycle disordersAkihiro Umezawa, Akinari Fukuda, Reiko Horikawa, et al.Journal of the American Heart Association|June 16, 2017
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failureFrancine Z Marques, Priscilla R Prestes, Sean G Byars, et al.Pageof 118